Is Discover A Better Stock Than Visa And Mastercard?

Credit card stocks have been on a roll so far in 2012. Visa Inc (NYSE:V) is up about 35%, and Mastercard Inc (NYSE:MA) has increased in value by about 25%. Both market leaders, however, lag Discover Financial Services (NYSE:DFS); that stock is up 60% year to date. Just as interesting, when looking at valuation metrics Discover looks to be cheaper than either of these peers. Its trailing P/E multiple is 9, and it trades at the same multiple of analyst consensus on its 2013 earnings; Visa and Mastercard’s forward P/Es are 19 and 18, respectively. It is certainly the case that Visa and Mastercard have more attractive brands, and are also considerably larger in terms of market capitalization (Discover’s equity is valued at $20 billion, with Mastercard at about three times that figure and Visa at just above $90 billion), and so we would expect them to trade at something of a premium. Yet the gap between Discover and these peers does seem high.

Discover Financial Services has gotten two recent downgrades, however (from Stifel Nicolaus and Argus) and it is possible that its string is coming to an end. Its interest income was up 6% in its most recent fiscal quarter (which ended in August) compared to a year earlier, which was in line with the growth rates it had showed in the first half of the fiscal year. With a rise in expenses, net income ended up being down 3%, as opposed to rising as it had in the first half of the year, though thanks to a reduction in share count earnings per share were up slightly. As we’ve mentioned, both the trailing and forward P/Es at Discover are 9. Taking into account analyst projections for a few more years out, the five-year PEG ratio is 0.8; this indicates that the stock is a good value according to sell-side analysts.

CITADEL INVESTMENT GROUP

Columbus Circle Investors, managed by Donald Chiboucis, cut its stake in Discover Financial Services by 12% during the second quarter of 2012 but still owned 5.7 million shares. However, the fund had a larger position in Mastercard and had about the same amount of money invested in Visa (find more stocks owned by Columbus Circle Investors). Billionaire Ken Griffin’s Citadel Investment Group added a large number of shares and had 3.2 million at the end of June (see more stock picks from Ken Griffin and Citadel). Cliff Asness’s AQR Capital Management also bought, owning 2 million shares at the end of the quarter (research Cliff Asness’s favorite stocks).

Visa and Mastercard’s most recent reported quarters ended in June, with revenue at both companies up about 10% in that quarter versus a year earlier. So they appear to be slightly beating Discover on the growth front, in addition to their other attractive characteristics. Still, it looks to us that they trade at too high a premium in terms of earnings. Two other credit card companies are American Express Company (NYSE:AXP) and Capital One Financial Corp. (NYSE:COF). American Express’s business, in terms of revenue and earnings, was about flat in the second quarter compared to the second quarter of 2011, and trades at 14 times trailing earnings. Again, we don’t think that the company’s better brand and more consistent performance warrants quite as great a premium as it currently trades at. Capital One is Discover’s closest contender in the value department; it trades at trailing and forward P/Es of 11 and 8, respectively. This is despite the fact that its second quarter went very badly, as the company reported lower earnings and a 90% drop in earnings from what it had done in the same period last year.

We would prefer Discover to Capital One as it trades at similar multiples and its business appears to be doing better. The other peers- including Mastercard and Visa- do still look too pricy, as while they do have a number of advantages as investments they just aren’t as good a value.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!